Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panel

Immunotherapy has revolutionized treatment of patients diagnosed with metastatic melanoma, where nearly half of patients receive clinical benefit. However, immunotherapy is also associated with immune-related adverse events, which may be severe and persistent. It is therefore important to identify p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kisistók, Judit, Christensen, Ditte Sigaard, Rasmussen, Mads Heilskov, Duval, Lone, Aggerholm-Pedersen, Ninna, Luczak, Adam Andrzej, Sorensen, Boe Sandahl, Jakobsen, Martin Roelsgaard, Oellegaard, Trine Heide, Birkbak, Nicolai Juul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles: Translational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470440/
https://www.ncbi.nlm.nih.gov/pubmed/37294123
http://dx.doi.org/10.1097/CMR.0000000000000903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470440/
https://www.ncbi.nlm.nih.gov/pubmed/37294123
http://dx.doi.org/10.1097/CMR.0000000000000903

Ejemplares similares